| Established | 2011 |
|---|---|
| Research type | Translational research |
Field of research | gene editing, gene therapy, genomics |
| Director | Brian Brown |
| Address | 1425 Madison Avenue, New York, NY 10029-6501 |
| Location | New York City |
| Affiliations | Icahn School of Medicine at Mount Sinai Mount Sinai Hospital, New York |
| Website | icahn |
The Icahn Genomics Institute is a biomedical and genomics research institute within the Icahn School of Medicine at Mount Sinai in New York City. Its aim is to establish a new generation of medicines that can better treat diseases afflicting the world, including cancer, heart disease and infectious pathogens. To do this, the institute’s doctors and scientists are developing and employing new types of treatments that utilize DNA and RNA based therapies, such as CRISPR, siRNA, RNA vaccines, and CAR T cells, and searching for novel drug targets through the use of functional genomics and data science. The institute is led by Brian Brown, a leading expert in gene therapy, genetic engineering, and molecular immunology.[1]